VEGFA and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease, where neurovascular dysfunction is a key early event, Endocan affects angiogenesis by interacting with VEGF and may also affect cerebral blood flow and oxygenation, which are critical for neuronal health.